The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center
|
|
|
- Jonah Benson
- 6 years ago
- Views:
Transcription
1 The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center Thomas Haberer, Scientific Technical Director, Heidelberg Ion Therapy Center
2 Situation / Indications 2/3 patients suffer from a local disease at the time of diagnosis In 18% local treatment modalities fail => organ at risk tumor Locations: brain, base of the skull, prostate, liver, lung Profile: deep-seated and radioresistant tumor close to organs at risk deaths/year in the EC Protons and ions have the potential to cure patients/year in the EC Th. Haberer, Heidelberg Ion Therapy Center tumor-conformal dose distribution
3 Rationale / Physics Advantageous physical characteristics: inverted depth-dose distribution Th. Haberer, Heidelberg Ion Therapy Center
4 Rationale / Physics Advantageous physical characteristics: small lateral scattering Th. Haberer, Heidelberg Ion Therapy Center
5 Rationale / Radiobiology RBE microscopic dose distributions Th. Haberer Depth in tissue cell nucleus [mm H 2 O]
6 H, Li, C, N, O? RBE for fractionated RT of gut crypt cells of mice (Berkeley) Proton data: Tepper et al Ion data: Goldstein et al Which Ion is optimal: Li, C, N, O? And: for which clinical indication?
7 Goal The key element to improve the clinical outcome is local control! entrance channel: low physical dose low rel. biol. effiency tumour: high physical dose high rel. biol. effiency
8 Reformulated Goal Delivery of biologically optimized and intensity-modulated dose distributions using a minimum amount of fractions even in the presence of organ motion.
9 Standard Approach Facilities being built at existing research accelerators Fixed energy machines with moderate flexibility (if at all) Dose delivery not exactly tumor-conform Th. Haberer, Heidelberg Ion Therapy Center
10 Standard / System + Dose Distr. typical set-up (Tsukuba) Distal edge shaping using a bolus pulls dose back into healthy tissue Th. Haberer, Heidelberg Ion Therapy Center
11 Carbon Ion Therapy at NIRS (June 1994-August 2004) Rectum 15 (1.2%) Eye 13 (1.0%) Miscell. 148 (11.4%) Pancreas 18 (1.4%) Lung 245 (18.9%) Base of skull 20 (1.5%) Esophagus 23 (1.8%) Brain 74 (5.7%) Total 2,297 Head & Neck 207 (16.0%) Uterus 78 (6.0%) Bone/ soft tissue 121 (9.3%) Liver 145 (11.2%) Prostate 190 (14.6%)
12 Results Before RT 48 months after RT Malignant melanoma 57.6GyE/16fx (NIRS)
13 Carbon Ion GSI Th. Haberer, Heidelberg Ion Therapy Center
14 Dose Delivery Concept Idea: Dose distributions of utmost tumor conformity can be produced by superimposing many thousands Bragg-peaks in 3D. Sophisticated requirements concerning the beam delivery system, the accelerator, the treatment planning, QA,... result from this approach. Realization: Dissect the treatment volume into thousands of voxels. Use small pencil beams with a spatial resolution of a few mm to fill each voxel with a precalculated amount of stopping particles taking into account the underlying physical and biological interactions. => Extreme intensity modulation Th. Haberer, Heidelberg Ion Therapy Center
15 Rasterscan Method scanning of focussed ion beams in fast dipole magnets active variation of the energy, focus and intensity in the accelerator and beam lines utmost precision via active position and intensity feed back loops intensity-controlled rasterscan GSI Haberer et al., NIM A, 1993
16 Rasterscan Method Protons (Pedroni et al., PSI): spot scanning gantry (1D magnetic pencil beam scanning) plus passive range stacking (digital range shifter) Ions (Haberer et al.): raster scanning (2D magnetic pencil beam scanning) plus active range stacking (spot size, intensity) in the accelerator Maximum dose conformality via pencil beam scanning Th. Haberer, Heidelberg Ion Therapy Center
17 Fluence Distribution of a Single Slice Th. Haberer, Heidelberg Ion Therapy Center
18 Advanced / Plan Comparison Ions vs. IMRT (precise X-rays) IMRT 9 fields Carbon 2 fields Th. Haberer, Heidelberg Ion Therapy Center
19 Key GSI Scanning-ready pencil beam library ( combinations): 253 energies (1mm range steps) x 7 spot sizes x 15 intensity steps Rasterscan method incl. approved controls and safety Beammonitors follow the scanned beams (v <= 40 m/s) in real-time Biological interactionmodel based on 25 years of radiobiological research Physical beam transportmodel Planningsystem TRiP In-beam Positron Emission Tomography QA system... Th. Haberer, Heidelberg Ion Therapy Center
20 Pre OP Results Post OP dose [%] chondro sarcoma rasterscanned carbon ions
21 FSRT / IMRT vs FSRT / IMRT+C12 at the locally advanced adenoid-cystic carzinoma survival acute toxicity acceptable late toxicity > CTC Grad 2 < 5% local control Schulz-Ertner, Cancer 2005 Th. Haberer
22 Heidelberg Ion Therapy Center compact design full clinical integration rasterscanning only low-let modality: Protons (later He) high-let modality: Carbon (Oxygen) ion selection within minutes world-wide first scanning ion gantry > 1000 patients/year > fractions/year Th. Haberer, Heidelberg Ion Therapy Center
23 Germany: Ion Some Facility Facts of the Heidelberg Start of construction: November 2003 Effective area m² Completion of building and acc.: June 2006 Concrete tons First patient planned: End of 2008 Constructional steel tons Capital Investment 100 M Project Partners: University pays, owns and operates the facility GSI built the accelerator Siemens supplies all components related to patient environment DKFZ is a research partner
24 HIT / General Requirements ions : p 3 He C 6 16 O 8+ energies (MeV/u) : (255 steps) beam spot size : 4-10 mm (2d-gaussian) ( 4 steps) treatment caves : 3 (2 horizontal, 1 iso-centric gantry) QA and research : 1 (1 horizontal) Th. Haberer, Heidelberg Ion Therapy Center
25 Injector RFQ + IH-DTL Ion sources Th. Haberer, Heidelberg Ion Therapy Center
26 high energy beam transport synchrotron Th. Haberer, Heidelberg Ion Therapy Center
27 Medical Equipment Identical patient positioning systems fixed beam gantry Workflow optimization automated QA procedures automated patient hand over from shuttle treatment chair Inroom position verification 2D 3D Cone beam CT Open for future applications and workflows Th. Haberer, Heidelberg Ion Therapy Center
28 Patient Positioning System Key Requirements Absolute position accuracy independent from patient weight R 0,5 mm Position correction in 6 degrees of freedom Roll & pitch in the isocenter in every treatment position Max. patient weight 200 kg Intuitive Handling Automated QA sequences Implementation of future applications via software only Prepared for automated patient table handover (external immobilization, immobile patients) Prepared for attachment of treatment chair
29 Patient Positioning System Functionality Isocentric Rotation +/-100 Pitch max. +/-15 Step On Position 650 mm Roll max. +/-15
30 Position Verification System Key Requirements 2D Orthogonal DR Imaging Flexible adjustment of X-ray projection axis Position verification in every treatment position 3D Cone Beam Imaging Integrated workflow for position correction X-ray system prepared for monitoring of moving organs
31 Patient Positioning System Workflow Optimization & Outlook Docking Mechanism with connectors QA Table Top with Water Phantom Automated Patient Hand Over Adaptation of Treatment Chair
32 Position Verification System Functionality
33 Status & Next Steps preliminary scanner commissioning result energy recorded in a verification film no feedback loops for beam intensity or position (courtesy S.O. Grözinger et al., Siemens Medical Solutions)
34 Motivation Gantry Advantage of a rotating beamline Pancreas, supine position via gantry advantageous Th. Haberer
35 Scanning Ion Gantry optimum dose application world-wide first ion gantry world-wide first integration of beam scanning 13m diameter 25m length 600to overall weight 0,5mm max. deformation prototype segment tested at GSI MT Aerospace MT Mechatronics Th. Haberer, Heidelberg Ion Therapy Center
36 Mounting
37 Gantry / Medtech
38 Gantry: first beam at the isocenter
39 Outlook Particle therapy will cover the full spectrum of radiotherapeutical indications Per 10 million inhabitants one particle therapy facility may be required. Upcoming: CNAO/Pavia, Rhön-Klinikum/Marburg, Kiel, MedAustron/Wiener Neustadt... GSI linac Th. Haberer, Heidelberg Ion Therapy Center CNAO Pavia Italy
40 Thank you for your attention!
The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center
The Heidelberg Ion Therapy Center and PARTNER Thomas Haberer Heidelberg Ion Therapy Center Goal The key element to improve the clinical outcome is local control! entrance channel: low physical dose low
The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009
The Heidelberg Ion Therapy Center Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 Goal The key element to improve the clinical outcome is local l control! entrance channel:
Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center
The Heidelberg Ion Beam Therapy Center A Hospital-based Facility Dedicated to Precision and Flexibility Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center Carbon Ion Therapy
The Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation. Presented at EPAC 2008, Genova D. Ondreka, GSI
The Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation Presented at EPAC 2008, Genova D. Ondreka, GSI Introduction Heidelberg Ion Therapy Centre: Europe's first dedicated particle therapy facility
New Treatment Research Facility Project at HIMAC
New Treatment Research Facility Project at Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences IPAC10, Kyoto, JAPAN, 25th May, 2010 Contents 1. Introduction
Review of Hadron machines for cancer therapy
Review of Hadron machines for cancer therapy M. Kanazawa NIRS cancer therapy with hadron (p, C) Clinical studies at New ideas of accelerators Compact facilities (p, C) Depth dose distribution Carbon, proton
Review of Heavy Ion Accelerators for Hadrontherapy
Review of Heavy Ion Accelerators for Hadrontherapy Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences 11 th Int l Conf. on Heavy Ion Accelerator Technology,
Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May
IONTRIS Synchrotron based PT Solutions from Siemens AG Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May 1 2009 Matthias Herforth VP Business Development and Communications Siemens AG
Heavy Ion Tumor Therapy
Heavy Ion Tumor Therapy Applications Bence Mitlasoczki 25.06.2018 Heidelberg 1. Source (H 2 /CO 2 ) 2. Linac 3. Synchrotron 4. Guide 5. Treatment rooms 6. X-ray system 7. Gantry 8. Treatment room with
Progress of Heavy Ion Therapy
Progress of Heavy Ion Therapy Fuminori Soga Division of Accelerator Physics and Engineering, National Institute of Radiological Sciences, 4-9-1 Anagawa. Inage-ku, Chiba 263-8555, Japan 1. Introduction
PROGRESS IN HADRONTHERAPY
PROGRESS IN HADRONTHERAPY Saverio Braccini TERA Foundation for Oncological Hadrontherapy IPRD06 - Siena - 01.10.06 - SB 1 Outline Introduction Radiation therapy with X rays and hadrontherapy Hadrontherapy
Activities at the Heidelberg Ion Therapy Center (HIT)
Activities at the Heidelberg Ion Therapy Center (HIT) The people A. Mairani (now INFN), F. Sommerer (Uniklinikum Heidelberg), I. Rinaldi (DKFZ Heidelberg), K. Parodi (HIT and University of Heidelberg)
IMPT with Carbon Ions
IMPT with Carbon Ions PTCOG 48, Heidelberg, 28.09.-03.10.2009 Malte Ellerbrock Medical Physics Expert Heidelberg Ion-Beam Therapy Center HIT Betriebs GmbH am Universitätsklinikum Heidelberg http://www.hit-centrum.de
Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning
Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca
III. Proton-therapytherapy. Rome SB - 5/5 1
Outline Introduction: an historical review I Applications in medical diagnostics Particle accelerators for medicine Applications in conventional radiation therapy II III IV Hadrontherapy, the frontier
Proton and heavy ion radiotherapy: Effect of LET
Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer
Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience
Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience Stephanie E. Combs, MD Department of Radiation Oncology University of Heidelberg, Germany Carbon ion RT at GSI Active beam delivery
Proton and helium beams: the present and the future of light ion beam therapy
Proton and helium beams: the present and the future of light ion beam therapy Dr. Andrea Mairani Group Leader Biophysics in Particle Therapy Heidelberg Ion Beam Therapy Center HIT Department of Radiation
ACCELERATORS FOR HADRONTHERAPY
ACCELERATORS FOR HADRONTHERAPY Alberto Degiovanni CERN-BE IVICFA s Fridays: Medical Physics Valencia, 31.10.2014 Introduction: the icon of hadrontherapy Position of the Bragg peak depends on beam energy
Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy -
Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Takeshi Murakami Research Center of Charged Particle Therapy National Institute of Radiological Sciences 2012.11.21 1. Introduction to
Current Status and Future Medical Perspectives at MedAustron. U. Mock EBG MedAustron GmbH
Current Status and Future Medical Perspectives at MedAustron U. Mock EBG MedAustron GmbH Cancer treatment facility Ion beam therapy with protons and carbon ions Research facility Medical physics Radiobiology
Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC
Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:
Introduction to Ion Beam Cancer Therapy
Introduction to Ion Beam Cancer Therapy Andrew M. Sessler (with some slides from David Robin) Lawrence Berkeley National Laboratory Berkeley, CA 94720 Cyclotron 10, Lanzhou September 10, 2010 Contents
Ion Beam Therapy should we prioritise research on helium beams?
Ion Beam Therapy should we prioritise research on helium beams? Stuart Green Medical Physics University Hospital Birmingham NHS Trust Follow-up from the EUCARD2 workshop, ION Beam Therapy: Clinical, Scientific
SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY
SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SAVERIO BRACCINI * Albert Einstein Centre for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse
Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine
Proton Therapy Dosimetry & Clinical Implementation Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Outline» Proton Therapy Basics» Why Proton Therapy? (Dosimetric Superiority)»
Basic Press Information
Basic Press Information Contact MedAustron EBG MedAustron GmbH Marie Curie-Strasse 5 A-2700 Wiener Neustadt Austria T +43 2622 26 100-0 e-mail: office@medaustron.at Internet: www.medaustron.at Press contact:
Tumor Therapy with Heavy Ions at GSI Darmstadt
Tumor Therapy with Heavy Ions at GSI Darmstadt D. Schardt 1) for the Heavy Ion Therapy Collaboration 2) 1) Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany 2) GSI Darmstadt / Radiologische
Present status and future of Proton beam therapy
Present status and future of Proton beam therapy Description At present, the types of proven treatment for cancer are surgery, radiotherapy, and chemotherapy. Depending on the characteristics of cancer
OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY
OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY Abstract The CNAO (National Centre for Oncological Hadrontherapy) has been realized in Pavia. It is a clinical facility created and financed by the Italian
ABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING.
P ROTON THERAPY C O- OPERATIVE GROUP Chair Michael Goitein Ph. D. Department of Radiation Oncology Massachusetts General Hospital Boston MA 02114 (617) 724-9529 (617) 724-9532 Fax Secret ary Janet Sisterson
FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017
FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips
ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER
ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER Bro. Dr. Collie Miller IARC/WHO Based on trends in the incidence of cancer, the International Agency for Research on Cancer (IARC) and WHO
PTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan)
PTCOG 46 Educational Workshop Session IV CLINICAL Head & Neck J. Mizoe (NIRS, Japan) Photon X-Ray γ-ray Fast Neutron Non-Charged Radiation Electron Proton Helium Light Ion Heavy Particle Carbon Neon Argon
Biological Optimization of Hadrontherapy. Uwe Oelfke
4/2/2012 page 1 Biological Optimization of Hadrontherapy Uwe Oelfke DKFZ Heidelberg (E040) Im Neuenheimer Feld 280 69120 Heidelberg, Germany u.oelfke@dkfz.de 4/2/2012 page 2 Contents Introduction and General
MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, *
Radiation Protection Dosimetry (2009), Vol. 137, No. 1 2, pp. 156 166 Advance Access publication 14 October 2009 doi:10.1093/rpd/ncp192 MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * 1
IN VIVO IMAGING Proton Beam Range Verification With PET/CT
IN VIVO IMAGING Proton Beam Range Verification With PET/CT Antje-Christin Knopf 1/3 K Parodi 2, H Paganetti 1, T Bortfeld 1 Siemens Medical Solutions Supports This Project 1 Department of Radiation Oncology,
Nuclear Data for Radiation Therapy
Symposium on Nuclear Data 2004 Nov. 12, 2004 @ JAERI, Tokai Nuclear Data for Radiation Therapy ~from macroscopic to microscopic~ Naruhiro Matsufuji, Yuki Kase and Tatsuaki Kanai National Institute of Radiological
Treatment Planning (Protons vs. Photons)
Treatment Planning Treatment Planning (Protons vs. Photons) Acquisition of imaging data Delineation of regions of interest Selection of beam directions Dose calculation Optimization of the plan Hounsfield
A brief presentation of The TERA Foundation
A brief presentation of The TERA Foundation David Watts on behalf of Prof. Ugo Amaldi and all my colleagues at TERA TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac
Your co-operation partner for research. EUROPEAN UNION European Regional Development Fund
Med Austron Research Your co-operation partner for research EUROPEAN UNION European Regional Development Fund MedAustron MedAustron offers protons and carbon ions for therapy and research. With MedAustron,
Cancer situation as presented by (EC 1991)
3.1 Proton and Heavy Ion Beam Therapy G. Kraft, GSI, Biophysik, Darmstadt and J. Debus, DKFZ, Heidelberg Motivation Cancer is the second most frequent cause for disease in the developed countries. Every
State-of-the-art proton therapy: The physicist s perspective
State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New
Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon
Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Introduction Why Particle Therapy? PT Milestones What is meant by Industrialization Examples Protons-only:
Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania
Proton Treatment Keith Brown, Ph.D., CHP Associate Director, Radiation Safety University of Pennsylvania Proton Dose vs. Depth Wilson,. R.R. Radiological use of fast protons. Radiology 47:487-491, 1946.
Status of H 1 and C 12
Status of H 1 and C 12 Herman Suit No Conflict of Interest 1 Goal of a New Treatment Modality Tumor Control Probability or No in Complication Rate 2 Truism No Advantage to: any Patient for any Radiation
Dosimetry and QA of proton and heavier ion beams
Dosimetry and QA of proton and heavier ion beams Stanislav Vatnitskiy EBG MedAustron GmbH Wiener Neustadt, Austria Content Introduction Reference dosimetry Methods, detectors, protocols Dosimetry in non-reference
Future upcoming technologies and what audit needs to address
Future upcoming technologies and what audit needs to address Dr R.I MacKay History of audit Absolute dose - Simple phantom standard dose measurement Point doses in beams - Phantoms of relatively simple
Proton Stereotactic Radiotherapy: Clinical Overview. Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS
Proton Stereotactic Radiotherapy: Clinical Overview Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS Acknowledgements Radiation Oncologists and Physicists at various institutions (MGH, MDACC,
Dr. Robert R. Wilson, a physicist who had worked on
Radiation Therapy With Charged Particles Daniela Schulz-Ertner, MD,* Oliver Jäkel, PhD, and Wolfgang Schlegel, PhD Charged particle beams can offer an improved dose conformation to the target volume as
A review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September
A review of cyclotrons for Hadron Therapy Y. Jongen Cyclotrons 2010 Lanzhou, September 10 2010 The early days The possible use of the Bragg peak of high energy ions in the radiotherapy of cancer was suggested
Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034
Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Saudi-Japan Business Opportunities Forum February 1 2, 2012 1 2 Types of Treatment Conventional Radiation Therapy Uses photons (energetic
Status of Proton Therapy: results and future trends
Status of Proton Therapy: results and future trends E. Pedroni Paul Scherrer Institute Division of Radiation Medicine CH-5232 Villigen PSI Abstract The number of centres investigating proton therapy in
Practical Challenges and Opportunities for Proton Beam Therapy. M. F. Moyers Loma Linda University Medical Center
Practical Challenges and Opportunities for Proton Beam Therapy M. F. Moyers Loma Linda University Medical Center Outline I. Introduction II. Registration and Immobilization III. Beam Shaping IV. Localization
Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR
Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR PhD, FAAPM, FACR, FASTRO Department of Radiation Oncology Indiana University School of Medicine Indianapolis, IN, USA Indra J. Das,
Proton Beam Therapy at Mayo Clinic
Proton Beam Therapy at Mayo Clinic Jon J. Kruse, Ph.D. Mayo Clinic Dept. of Radiation Oncology Rochester, MN History of Proton Therapy at Mayo 2002: Decided to consider particle therapy analysis and education
SUMITOMO Particle Therapy Technologies
55 th AAPM annual meeting Particle Beam Therapy Symposium SUMITOMO Particle Therapy Technologies August 3, 2013 Yukio Kumata Experience accelerators for science Current Status proton and carbon Future
Image Guided Proton Therapy and Treatment Adaptation
Image Guided Proton Therapy and Treatment Adaptation www.hollandptc.nl d.r.schaart@tudelft.nl Cancer in The Netherlands About 1 in 3 people get cancer in some stage of their life 86.800 new cancer patients
Verification of micro-beam irradiation
Journal of Physics: Conference Series OPEN ACCESS Verification of micro-beam irradiation To cite this article: Qiongge Li et al 2015 J. Phys.: Conf. Ser. 573 012047 View the article online for updates
Heavy Ion Therapy: Status and Perspectives
Technology in Cancer Research & Treatment ISSN 1533-0346 Volume 2, Number 5, October (2003) Adenine Press (2003) Heavy Ion Therapy: Status and Perspectives www.tcrt.org Starting with the pioneering work
Status of Hadrontherapy facilities worldwide
Status of Hadrontherapy facilities worldwide Vienna 15.03.2011 The Gantry 1 of PSI Eros Pedroni Center for Proton Radiation Therapy Paul Scherrer Institute SWITZERLAND Author s competence: Gantry with
Plans for the Precision Cancer Medicine Institute University of Oxford
Plans for the Precision Cancer Medicine Institute University of Oxford STFC & Particle Accelerators and Beams group workshop on particle accelerators for medicine 17 th February 2015 Claire Timlin The
CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section
CERN: from particle physics to medical applications Manuela Cirilli CERN Knowledge Transfer Life Sciences Section The mission of CERN Research Innovation Push forward the frontiers of knowledge Develop
Hampton University Proton Therapy Institute
Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI
HEAVY PARTICLE THERAPY
HEAVY PARTICLE THERAPY DR. G.V. GIRI KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY ICRO 2012 BHATINDA HEAVY PARTICLES USED IN A EFFORT TO IMPROVE TUMOR CONTROL, THAT DO NOT RESPOND TO PHOTONS OR ELECTRONS BETTER
I. Equipments for external beam radiotherapy
I. Equipments for external beam radiotherapy 5 linear accelerators (LINACs): Varian TrueBeam 6, 10 & 18 MV photons, 6-18 MeV electrons, image-guided (IGRT) and intensity modulated radiotherapy (IMRT),
Simulating Potential Layouts for a Proton Therapy Treatment Center
Simulating Potential Layouts for a Proton Therapy Treatment Center Stuart Price-University of Maryland Bruce Golden- University of Maryland Edward Wasil- American University Howard Zhang- University of
Verification of treatment planning system parameters in tomotherapy using EBT Radiochromic Film
Verification of treatment planning system parameters in tomotherapy using EBT Radiochromic Film E.B.Rajmohan¹, Pratik Kumar¹, Bhudatt Paliwal,² David Westerly², N.Gopishankar³, R.K.Bisht³, D.Tewatia²,
Recent advances in dosimetry in reference conditions for proton and light-ion beams
Recent advances in dosimetry in reference conditions for proton and light-ion beams S. Vatnitskiy a), P. Andreo b) and D.T.L. Jones c) a) MedAustron, Wiener Neustadt, Austria b) Medical Radiation Physics,
A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe
SEEIIST South East Europe International Institute for Sustainable Technologies A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe U. Amaldi a, J. Balosso b, M. Dosanjh
Radiosurgery. Most Important! 8/2/2012. Stereotactic Radiosurgery: State of the Art Technology and Implementation Linear Accelerator Radiosurgery
Therapy SAM Symposium: WE-A-BRCD-1 Stereotactic Radiosurgery: State of the Art Technology and Implementation Linear Accelerator Radiosurgery Kamil M. Yenice, PhD Associate Professor Chief of Clinical Physics
CyberKnife Technology in Ablative Radiation Therapy. Jun Yang PhD Cyberknife Center of Philadelphia Drexel University Jan 2017
CyberKnife Technology in Ablative Radiation Therapy Jun Yang PhD Cyberknife Center of Philadelphia Drexel University Jan 2017 Objectives Components and work flow of CyberKnife Motion management of CyberKnife
Intensity Modulated RadioTherapy
Intensity Modulated RadioTherapy A clinical application of a small accelerator University Medical Center Groningen A.A. van t Veld PhD I. Hoveijn PhD part 1 part2 CERN/KVI accelerator school, Zeegse, June
Heidelberg Ion-Beam Therapy Centre (HIT) officially opened
Powered by Website address: https://www.gesundheitsindustrie-bw.de/en/article/pressrelease/heidelberg-ion-beam-therapy-centre-hit-officiallyopened/ Heidelberg Ion-Beam Therapy Centre (HIT) officially opened
Tumortherapy with ion beams
Nuclear Instruments and Methods in Physics Research A 454 (2000) 1}10 Tumortherapy with ion beams G. Kraft* For the Heavy Ion Therapy collaboration GSI Biophysik, Planckstrasse 1, 64291 Darmstadt, Germany
SRS Uncertainty: Linac and CyberKnife Uncertainties
SRS Uncertainty: Linac and CyberKnife Uncertainties Sonja Dieterich, PhD Linac/CyberKnife Technological Uncertainties 1 Linac Mechanical/Radiation Isocenters Depuydt, Tom, et al. "Computer aided analysis
COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE
COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE I. Petrovi a, A. Risti -Fira a, L. Kori anac a, J. Požega a, F. Di Rosa b, P. Cirrone b and G. Cuttone
Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques
TROG 08.03 RAVES Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques Introduction Commissioning and quality assurance of planning systems and treatment delivery
Elekta Synergy Digital accelerator for advanced IGRT
Elekta Synergy Digital accelerator for advanced IGRT Setting the standard for confident care The Field of Radiation Therapy is Constantly Changing Being able to take full advantage of the latest clinical
Nuclear Physics in Proton Radiotherapy
Nuclear Physics in Proton Radiotherapy Cynthia Keppel, PhD Thomas Jefferson National Accelerator Facility (Hampton University Proton Therapy institute) International Nuclear Physics Conference Adelaide,
ACCELERATOR DESIGN ISSUES IN CANCER THERAPY
ACCELERATOR DESIGN ISSUES IN CANCER THERAPY December 25 P.J. Bryant CERN John ADAMS Memorial Lecture 25- P.J. Bryant - Slide 1 Contents Introduction Hadrons & voxel scanning Experimental setup A closer
Online Care, Online Control, Online Confidence
Online Care, Online Control, Online Confidence * Online Treatment Monitoring and much more! Designed for Efficiency provides you with online control and online confidence of treating your patients exactly
Modern Hadron Therapy Gantry Developments. 16th Jan 2014
Modern Hadron Therapy Gantry Developments 16th Jan 2014 Protect, Enhance, and Save Lives - 2 - IBA ProteusONE THE TREND: MORE COMPACT, CHEAPER Access to PT is key ProteusPLUS ProteusONE 18000 ft² / 1672
Elekta - a partner and world-leading supplier
Experience Elekta Elekta - a partner and world-leading supplier of clinical solutions for image guided radiation therapy, stereotactic radiotherapy, radiosurgery and brachytherapy, as well as advanced
Overview of Advanced Techniques in Radiation Therapy
Overview of Advanced Techniques in Radiation Therapy Jacob (Jake) Van Dyk Manager, Physics & Engineering, LRCP Professor, UWO University of Western Ontario Acknowledgements Glenn Bauman Jerry Battista
Clinical Education A comprehensive and specific training program. carry out effective treatments from day one
Proton Therapy Clinical Education A comprehensive and specific training program carry out effective treatments from day one Forewarned is forearmed Although over 100,000 patients have been treated in proton
T.Kanai, K. Yusa, M. Tashiro, H. Shimada, K. Torikai, Gunma University, Gunma, Japan
The carbon-ion cancer therapy facility at Gunma University T.Kanai, K. Yusa, M. Tashiro, H. Shimada, K. Torikai, J. Koya, T. Ishii, Y. Yoshida, S. Yamada, T. Ohno, T. Nakano Gunma University, Gunma, Japan
Advances in external beam radiotherapy
International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada
Look! Borg get upgrade already!
Cancer, Partikel Terapi and PT accelerators Look! Borg get upgrade already! 1 Cancer, Partikel Terapi and PT accelerators Basic requirements to PT accelerator Accelerators for PT Siemens PT maskinen Alternativer:
A BETTER TOMORROW STARTS WITH THE BEST OF TODAY PATIENT BROCHURE
A BETTER TOMORROW STARTS WITH THE BEST OF TODAY PATIENT BROCHURE 1 WELCOME TO THE CALIFORNIA PROTONS CANCER TREATMENT CENTER Patient Care is at the Center of Everything We Do Located in San Diego, California
An Introduction to Cancer Therapy With Hadron Radiation
An Introduction to Cancer Therapy With Hadron Radiation Andrew M. Sessler Lawrence Berkeley National Laboratory Berkeley, CA 94720 April, 2008 Contents 1. History 2. X-Ray Machines 3. Why Hadrons? Which
Medical Dosimetry Graduate Certificate Program IU Graduate School & The Department of Radiation Oncology IU Simon Cancer Center
Medical Dosimetry Graduate Certificate Program IU Graduate School & The Department of Radiation Oncology IU Simon Cancer Center All students accepted into the Medical Dosimetry Graduate Certificate Program
PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)
PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) Course Description: This course is an introduction to physics in medicine and is intended to introduce
RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident
Resident s Name: RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident Rotation: PHYS 703: Clinical Rotation 2 Inclusive dates of rotation: Feb. 26, 2016 Aug. 25, 2016 Director or Associate
Disclosure. Outline. Machine Overview. I have received honoraria from Accuray in the past. I have had travel expenses paid by Accuray in the past.
Clinical Implementation of the CyberKnife Disclosure I have received honoraria from Accuray in the past. I have had travel expenses paid by Accuray in the past. Mary Ellen Masterson-McGary McGary CyberKnife
Hypofractionation in particle therapy. Marco Durante
Hypofractionation in particle therapy Marco Durante 29.04.2014 Radiosurgery (SBRT): the new frontier in stereotactic imageguided radiotherapy Stage I (T1N0M0) NSCLC Oligometastases Hepatocellular carcinoma
Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy
Radiation Dosimetry for Proton Therapy Narayan Sahoo Department of Radiation Physics University of Texas MD Anderson Cancer Center Proton Therapy Center Houston, USA Topics covered Detectors used for to
Medical physics is beautiful
Translational research in particle therapy Marco Durante Medical physics is beautiful Pisa, 31.10.2014 Relative dose 1. 2 1. 0 Tumor Durante & Loeffler, Nature Rev Clin Oncol 2010 0. 8 Normal tissue 0.
Amendment No. 2. Item No. 2 (Rfx/ Event number )
Amendment 2 Sub: Amendment to the Document 06.12.2018 Ref.: Notice Inviting Bid ref. HITES/PCD/NCI-AIIMS/36/18-19 dated 26.09.2018 read with its Amendment no. 1 dated 19.11.18 The following changes have